Saskia Zvorc

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau et al. · The Lancet Respiratory Medicine · 2021 · 355 citations · Full text

Life Sciences, Immunology, Immunization +13

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 217 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19)

Florian Kurth, Maria Roennefarth, Charlotte Thibeault et al. · Infection · 2020 · 111 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +15

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1-nCoV19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau et al. · medRxiv · 2021 · 73 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study

Charlotte Thibeault, Barbara Mühlemann, Elisa T. Helbig et al. · Infection · 2021 · 31 citations · Full text

Engineering, Infectious Diseases, Hospital Medicine +13